Liatte Krueger
FDA investigator
Appears on 2 documents from 2016, mostly at sites in New Jersey. Most often cites testing and release for distribution (21 CFR 211.165).
- 2
- Documents on file
- 8.0
- Observations per 483
- 2016
- First seen
- 2016
- Most recent
What they cite most
From 16 observations- 21 CFR 211.165Testing and release for distribution3
- 21 CFR 314.80Postmarketing reporting of adverse drug experiences3
- 21 CFR 211.113Control of microbiological contamination2
- 21 CFR 211.22Responsibilities of quality control unit2
- 21 CFR 211.160General requirements1
- 21 CFR 211.167Special testing requirements1
Activity by year
2016: 2
Where
New Jersey 2
Often inspects with
Is Liatte Krueger coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2016-08-22 | 483 Town and Country Compounding and Consultation Services, LLCAug 22, 2016 · Ridgewood, New Jersey | Ridgewood, New Jersey | 7 | |
| 2016-02-02 | 483 Elite Laboratories IncFeb 2, 2016 · Northvale, New Jersey | Northvale, New Jersey | 9 |
About this profile
What does Liatte Krueger inspect?
Liatte Krueger appears on 2 documents on file covering 2 sites, mostly in New Jersey.
What do they cite most often?
21 CFR 211.165 (testing and release for distribution), followed by 21 CFR 314.80 and 21 CFR 211.113.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Liatte Krueger is dated Aug 22, 2016.